This site is intended for healthcare professionals
Last reviewed dd mmm yyyy. Last edited dd mmm yyyy
A randomized, double-blind, placebo controlled trial (Fracture intervention Trial FIT) performed by Black et al (Lancet 1996) has revealed that alendronate safely reduced the frequency of vertebral and nonvertebral fractures in postmenopausal women with low bone mass density.
1022 women were assigned to the alendronate (treatment group) and 1005 women were assigned to placebo.